'Hmg coa reductase inhibitors' presentation slideshows

Treatment of Lipid Disorders

Treatment of Lipid Disorders. Ulrich K. Schubart AECOM/JMC. Prevention, slowed progression, or regression of. atherosclerotic lesions. Stabilization of atherosclerotic lesions. - Especially non-obstructive , vulnerable plaques.

1.16k views • 76 slides

Cholesterol: The Expanded Lipid Profile

Cholesterol: The Expanded Lipid Profile. Ben Brown MD December 19, 2011 Thanks also to Wendy K and Fasih H. Outline. What is the expanded lipid panel? Why order it? How to order it? What to do with results? Cases Questions. Cases.

917 views • 55 slides

ATHEROSCLEROSIS HYPERLIPIDEMIA

???? ???. ATHEROSCLEROSIS HYPERLIPIDEMIA. ?????? ? ???? ?? ??????????? ? ? ? ?? ? ? ? ? ?? ?. Leading Causes of Death Worldwide ( % ). Ischemic Heart Disease 12.4 % Cerebro-Vascular Accident 8.7 Lower Respiratory Infection 8.5

751 views • 47 slides

LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categorie

481 views • 32 slides

Global Statin Market 2015 - Size, Trends, Growth & Forecast to 2019

Global Statin Market, report covers the present scenario and the growth prospects of the global statin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of statins used for the management of lipid abnormalities and lipid-associated comorbidities such as stroke and coronary heart disease. This report provides a discussion of the market in the following three regions: Americas, APAC, and EMEA. Global Statin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Read more details at: http://www.bigmarketresearch.com/global-statin-2015-2019-market

409 views • 6 slides